Research Topics
Prolonged CAR-T cell expansion and stemness in heavily pretreated relapsed/refractory B-ALL and B-NHL patients treated with CD19CAR incorporated CD28/CD40 co-stimulatory molecule: A preliminary outcome of academic PSU CD19CAR-T cell
Researchers
Jakrawadee Julamanee,
Panarat Noiperm, Watsamon Uraiwan1,
Kajornkiat Maneechai,
Chaweewan Punsuk,
Pornpun Sripornsawan,
Umaporn Yam-Ubon,
Thirachit Chotsampancharoen,
Wannakorn Khopanlert,
Supannikar Tawinwung,
Koramit Suppipat, and Seitaro Terakura
Institute
- Stem Cell Transplantation and Cellular Therapy Excellence Center, Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand
- Hematology Unit, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
- Thailand Hub of Talents in Cancer Immunotherapy (TTCI), Thailand
- Hematology and Oncology Unit, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
- Anatomical Pathology Unit, Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
- Chulalongkorn University Cancer Cellular Therapy research group, Cancer Immunotherapy Excellence Center, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Funding
Faculty of Medicine, Prince of Songkla University
Timeline
October 2024-2027